[en] Burki lymphoma (BL) is a highly aggressive B-cell neoplasm with poor overall survival in cases
of refractory or relapsed disease. Standard-of-care strategies in these situa ons remain
undefined. A recent retrospec ve study evalua ng chimeric an gen receptor (CAR) T-cell
therapy in refractory BL reported disappoin ng outcomes.
We describe a case of CAR T-cell detec on following autologous hematopoie c stem cell
transplanta on (auto-HCT) a er CAR T-cell-based salvage therapy.
Disciplines :
Hematology
Author, co-author :
NELLESSEN, Julie ; Département de médecine interne > Service d'hématologie clinique
De Voeght, Adrien ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Willems, Evelyne ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
DE PRIJCK, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Sid Selim
Caers, Jo ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
GREGOIRE, Céline ✱; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
MAQUET, Claire ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
✱ These authors have contributed equally to this work.
Language :
English
Title :
DETECTION OF CIRCULATING CD19-DIRECTED CAR T-CELLS FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Publication date :
February 2026
Event name :
41st General Annual Meeting of the Belgian Hematology Society 2026
